Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial

por Balcells, María Elvira, Rojas, Luis, Le Corre, Nicole, Martínez-Valdebenito, Constanza, Ceballos, María Elena, Ferrés, Marcela, Chang, Mayling, Vizcaya, Cecilia, Mondaca, Sebastián, Huete, Álvaro, Castro, Ricardo, Sarmiento, Mauricio, Villarroel, Luis, Pizarro, Alejandra, Ross, Patricio, Santander, Jaime, Lara, Bárbara, Ferrada, Marcela, Vargas-Salas, Sergio, Beltrán-Pavez, Carolina, Soto-Rifo, Ricardo, Valiente-Echeverría, Fernando, Caglevic, Christian, Mahave, Mauricio, Selman, Carolina, Gazitúa, Raimundo, Briones, José Luis, Villarroel-Espindola, Franz, Balmaceda, Carlos, Espinoza, Manuel A., Pereira, Jaime, Nervi, Bruno
Publicado 2021